文献速递主动脉疾病

超低profile装置经皮EVAR后锚定胶原塞股动脉止血的前瞻性审计

Femoral Arterial Haemostasis Using an Anchored Collagen Plug after Percutaneous EVAR with an Ultra-Low Profile Device: Prospective Audit of an Evolving "Post-Close" Technique.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-06-09

该前瞻性审计评估了使用Ovation超低profile装置行经皮EVAR后,采用Angio-Seal VIP血管闭合器进行「后关闭」止血技术的效果。26例完全经皮患者中,总体即刻止血成功率为100%,住院时间平均2天,2例出现股动脉假性动脉瘤经凝血酶注射治愈。结论认为该技术可行,8F Angio-Seal通常能有效闭合12F股动脉缺损。

要点

  • 超低profile装置经皮EVAR后可用Angio-Seal行「后关闭」止血。
  • 8F Angio-Seal通常可闭合12F股动脉缺损。
  • 26例经皮患者即刻止血成功率100%,2例假性动脉瘤经凝血酶治愈。

核心结论

  • 使用超低profile装置行经皮EVAR后,可采用「后关闭」技术成功止血。
  • 8F Angio-Seal通常能有效闭合12F股动脉缺损,是该场景下可行的股动脉闭合选择。

研究设计与样本

  • 记录患者体型、手术细节、血管闭合器数量(含双导丝法)及技术成功/并发症。

主要发现

  • 26例经皮患者中,同侧鞘管尺寸为14F(n=22)、15F(n=3)、16F(n=1)。
  • 同侧闭合使用单个8F Angio-Seal(n=7)、8F/6F组合(n=18)或两个8F(n=1)并预先双导丝设置。
  • 对侧穿刺多使用单个8F Angio-Seal(n=24)或8F/6F组合(n=2)闭合缩减至12F的缺损。
  • 总体即刻止血成功率为100%,经皮队列平均住院时间为2天(SD 1.5)。
  • 术后CTA(n=24)或双功超声(n=2)未发现狭窄或血清肿;2例出现同侧股动脉假性动脉瘤,经凝血酶注射成功治疗。

临床怎么用

  • 对于使用超低profile装置行经皮EVAR的患者,可考虑采用Angio-Seal行「后关闭」止血。
  • 8F Angio-Seal可用于闭合12F股动脉缺损,必要时采用8F/6F组合或双导丝法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To present an audit of a successful "post-close" haemostatic technique using the Angio-Seal VIP vascular closure device (VCD) after percutaneous endovascular aneurysm repair (p-EVAR) using an ultra-low profile (ULP) device. METHODS: Thirty patients underwent EVAR using the Ovation device, of which 26 procedures were totally percutaneous. Data including patient habitus, procedural details, number of VCDs deployed including use of the double wire approach, and technical success/complications were prospectively recorded. Numerical/statistical analyses were undertaken using Microsoft Excel 2007 and Minitab for Windows. RESULTS: Thirty consecutive patients (27 male, 3 female; age range 70-85 years [mean 76.1, SD 6.5]) underwent EVAR for an infrarenal AAA (mean size 61 mm, SD 9.7) between March 2014 and August 2016 using the Ovation endograft system. In a few patients open ipsilateral femoral access was used (n=4); the remainder underwent p-EVAR (n=26), and these results are presented hereafter. Ipsilateral sheath sizes used varied between 14F (n=22), 15F (n=3), and 16F (n=1), and were closed using a single 8F Angio-Seal (n=7), a combination of 8F/6F Angio-Seal VCDs (n=18), or two 8F Angio-Seal VCDs (n=1) with prior double wire set up. Contralateral punctures were closed mostly with a single 8F Angio-Seal (n=24) or combination of 8F/6F Angio-Seal VCDs (n=2) to seal defects downsized to 12F. The overall immediate haemostasis success rate was 100%. Mean length of stay in the p-EVAR cohort was 2 days (SD 1.5). All patients had a post-EVAR computed tomography angiogram (n=24) or duplex ultrasound (n=2) which did not reveal any stenoses or seromas; two patients developed an ipsilateral femoral pseudoaneurysm successfully treated by thrombin injection. CONCLUSION: A "post-close" technique can be employed successfully for haemostasis after p-EVAR using an ULP device. An 8F Angio-Seal is usually effective in closing a 12F femoral arterial defect. This represents a viable option for femoral arterial closure in this scenario.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chaudhuri A. Femoral Arterial Haemostasis Using an Anchored Collagen Plug after Percutaneous EVAR with an Ultra-Low Profile Device: Prospective Audit of an Evolving "Post-Close" Technique. Eur J Vasc Endovasc Surg. 2017. PMID: 28602578. doi:10.1016/j.ejvs.2017.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。